Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles
Iñaki Osorio-Querejeta, Susana Carregal‐Romero, Ana Ayerdi-Izquierdo, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 68

Showing 26-50 of 68 citing articles:

Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
Ariane Mwema, Giulio G. Muccioli, Anne des Rieux
Journal of Controlled Release (2023) Vol. 364, pp. 435-457
Closed Access | Times Cited: 11
The Role of MicroRNAs in Repair Processes in Multiple Sclerosis
Conor P. Duffy, Claire E. McCoy
Cells (2020) Vol. 9, Iss. 7, pp. 1711-1711
Open Access | Times Cited: 32
Application of Mesenchymal Stem Cells in Targeted Delivery to the Brain: Potential and Challenges of the Extracellular Vesicle-Based Approach for Brain Tumor Treatment
Anh Duy, Ida Kurniawati, Chia‐Ling Hsieh, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11187-11187
Open Access | Times Cited: 27
Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis
María Gutiérrez‐Fernández, Fernando de la Cuesta, Antonio Tallón, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9011-9011
Open Access | Times Cited: 26
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
Pauline van Schaik, Inge S. Zuhorn, Wia Baron
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8418-8418
Open Access | Times Cited: 19
Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis
Niloufar Rahiman, Marzieh Mohammadi, Seyedeh Hoda Alavizadeh, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 620-644
Closed Access | Times Cited: 17
Functionalized retinoic acid lipid nanocapsules promotes a two-front attack on inflammation and lack of demyelination on neurodegenerative disorders
Rui Pedro Moura, Eva Daniela Carvalho, Cláudia Martins, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 43-58
Open Access | Times Cited: 11
Influence of age and sex on microRNA response and recovery in the hippocampus following sepsis
Asha Rani, Jolie Barter, Ashok Kumar, et al.
Aging (2022) Vol. 14, Iss. 2, pp. 728-746
Open Access | Times Cited: 15
Exosomes in multiple sclerosis and Alzheimer's disease – Adversary and ally
Norina Tang
Biomedical Journal (2023) Vol. 47, Iss. 5, pp. 100665-100665
Open Access | Times Cited: 9
MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
Susana Carregal‐Romero, Lucía Fadón, Edurne Berra, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3253-3253
Open Access | Times Cited: 23
Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
Doddy Denise Ojeda-Hernández, Mercedes A. Hernández-Sapiéns, Edwin E. Reza-Zaldívar, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1417-1417
Open Access | Times Cited: 13
Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles
Anagha Aneesh, Alice Liu, Heather E. Moss, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Assessment of circulating extracellular vesicles from calorie‐restricted mice and humans in ischaemic injury models
Manuel S. V. Jaimes, Chia‐Te Liao, Max M. Chen, et al.
Journal of Extracellular Biology (2023) Vol. 2, Iss. 5
Open Access | Times Cited: 7
Roles of Extracellular Vesicles in Multiple Sclerosis: From Pathogenesis to Potential Tools as Biomarkers and Therapeutics
Cristiana Pistono, Cecilia Osera, Mariaclara Cuccia, et al.
Sclerosis (2023) Vol. 1, Iss. 2, pp. 91-112
Open Access | Times Cited: 7
Programmable DNA Nanodevices for Applications in Neuroscience
Pravin Hivare, Chinmaya Panda, Sharad Gupta, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 3, pp. 363-377
Closed Access | Times Cited: 16
IFNγ-stimulated dendritic cell extracellular vesicles can be nasally administered to the brain and enter oligodendrocytes
Kae M. Pusic, Richard P. Kraig, Aya D. Pusic
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255778-e0255778
Open Access | Times Cited: 15
Exosomes and MicroRNAs in Biomedical Science
Hamed Mirzaei, Neda Rahimian, Hamid Reza Mirzaei, et al.
Synthesis lectures on biomedical engineering (2022) Vol. 17, Iss. 1, pp. 1-175
Open Access | Times Cited: 11
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
María Muñoz‐San Martín, Imma Gómez, Ana Quiroga‐Varela, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Systematic Assessment of Small RNA Profiling in Human Extracellular Vesicles
Jing Wang, Hua‐Chang Chen, Quanhu Sheng, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3446-3446
Open Access | Times Cited: 6
Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes
Shanshan Guo, Chun‐Xia Yi
Nanotechnology Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
A review: oligodendrocytes in neuronal axonal conduction and methods for enhancing their performance
Jino Affrald R, Shoba Narayan
International Journal of Neuroscience (2024), pp. 1-22
Closed Access | Times Cited: 2
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels
Rossella Brandi, Marietta Fabiano, Corinna Giorgi, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 405-405
Open Access | Times Cited: 12
Nanosystems and exosomes as future approaches in treating multiple sclerosis
Marta Sidoryk‐Węgrzynowicz, Beata Dąbrowska‐Bouta, Grzegorz Sułkowski, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 9, pp. 7377-7404
Closed Access | Times Cited: 12
Combinatorial microRNA Loading into Extracellular Vesicles for Increased Anti-Inflammatory Efficacy
Alex Eli Pottash, Daniel Levy, Anjana Jeyaram, et al.
Non-Coding RNA (2022) Vol. 8, Iss. 5, pp. 71-71
Open Access | Times Cited: 8
Extracellular vesicles as contributors in the pathogenesis of multiple sclerosis
S Zamboni, Antonella D’Ambrosio, Paola Margutti
Multiple Sclerosis and Related Disorders (2023) Vol. 71, pp. 104554-104554
Closed Access | Times Cited: 4

Scroll to top